» Articles » PMID: 25285167

MicroRNAs Associated with HBV Infection and HBV-related HCC

Overview
Journal Theranostics
Date 2014 Oct 7
PMID 25285167
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatitis B virus (HBV) infection is a global problem and a major risk factor for hepatocellular carcinoma (HCC). microRNAs (miRNAs) comprise a group of small noncoding RNAs regulating gene expression at the posttranslational level, thereby participating in fundamental biological processes, including cell proliferation, differentiation, and apoptosis. In this review, we summarize the roles of miRNAs in HBV infection, the recently identified mechanism underlying dysregulation of miRNAs in HBV-associated HCC, and their association with hepatocarcinogenesis. Moreover, we discuss the recent advances in the use of circulating miRNAs in the early diagnosis of HCC as well as therapies based on these aberrantly expressed miRNAs.

Citing Articles

Independent prognostic significance of tissue and circulating microrna biomarkers in hepatocellular carcinoma.

Jeng L, Chan W, Teng C Discov Oncol. 2025; 16(1):281.

PMID: 40056315 PMC: 11890906. DOI: 10.1007/s12672-025-02043-y.


miRNA‑mRNA network contributes to HBV‑related hepatocellular carcinoma via immune infiltration induced by GRB2.

Zheng C, Su H, Liu M, Qian Y, Fan H Biomed Rep. 2024; 20(6):90.

PMID: 38682088 PMC: 11046184. DOI: 10.3892/br.2024.1777.


Serum microRNA Profiles and Pathways in Hepatitis B-Associated Hepatocellular Carcinoma: A South African Study.

Sartorius K, Sartorius B, Winkler C, Chuturgoon A, Shen T, Zhao Y Int J Mol Sci. 2024; 25(2).

PMID: 38256049 PMC: 10815595. DOI: 10.3390/ijms25020975.


Function and biomedical implications of exosomal microRNAs delivered by parenchymal and nonparenchymal cells in hepatocellular carcinoma.

Wang H, Yin W, Jiang M, Han J, Kuai X, Sun R World J Gastroenterol. 2023; 29(39):5435-5451.

PMID: 37900996 PMC: 10600808. DOI: 10.3748/wjg.v29.i39.5435.


Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma.

Zhang M, Yuan Y, Liu L, Wei Y, Yin W, Zheng L World J Gastroenterol. 2023; 29(31):4706-4735.

PMID: 37664153 PMC: 10473924. DOI: 10.3748/wjg.v29.i31.4706.


References
1.
Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y . CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 2010; 38(16):5366-83. PMC: 2938198. DOI: 10.1093/nar/gkq285. View

2.
Arataki K, Hayes C, Akamatsu S, Akiyama R, Abe H, Tsuge M . Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B. J Med Virol. 2013; 85(5):789-98. DOI: 10.1002/jmv.23540. View

3.
Datta J, Kutay H, Nasser M, Nuovo G, Wang B, Majumder S . Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res. 2008; 68(13):5049-58. PMC: 2562630. DOI: 10.1158/0008-5472.CAN-07-6655. View

4.
Huang S, He X . The role of microRNAs in liver cancer progression. Br J Cancer. 2010; 104(2):235-40. PMC: 3031886. DOI: 10.1038/sj.bjc.6606010. View

5.
Wang Y, Toh H, Chow P, Chung A, Meyers D, Cole P . MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms. FASEB J. 2012; 26(7):3032-41. PMC: 3382089. DOI: 10.1096/fj.11-201855. View